Literature DB >> 21826555

VSDMIP 1.5: an automated structure- and ligand-based virtual screening platform with a PyMOL graphical user interface.

Álvaro Cortés Cabrera1, Rubén Gil-Redondo, Almudena Perona, Federico Gago, Antonio Morreale.   

Abstract

A graphical user interface (GUI) for our previously published virtual screening (VS) and data management platform VSDMIP (Gil-Redondo et al. J Comput Aided Mol Design, 23:171-184, 2009) that has been developed as a plugin for the popular molecular visualization program PyMOL is presented. In addition, a ligand-based VS module (LBVS) has been implemented that complements the already existing structure-based VS (SBVS) module and can be used in those cases where the receptor's 3D structure is not known or for pre-filtering purposes. This updated version of VSDMIP is placed in the context of similar available software and its LBVS and SBVS capabilities are tested here on a reduced set of the Directory of Useful Decoys database. Comparison of results from both approaches confirms the trend found in previous studies that LBVS outperforms SBVS. We also show that by combining LBVS and SBVS, and using a cluster of ~100 modern processors, it is possible to perform complete VS studies of several million molecules in less than a month. As the main processes in VSDMIP are 100% scalable, more powerful processors and larger clusters would notably decrease this time span. The plugin is distributed under an academic license upon request from the authors. © Springer Science+Business Media B.V. 2011

Mesh:

Substances:

Year:  2011        PMID: 21826555     DOI: 10.1007/s10822-011-9465-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  40 in total

1.  VSDocker: a tool for parallel high-throughput virtual screening using AutoDock on Windows-based computer clusters.

Authors:  Nikita D Prakhov; Alexander L Chernorudskiy; Murat R Gainullin
Journal:  Bioinformatics       Date:  2010-04-08       Impact factor: 6.937

2.  SOMA--workflow for small molecule property calculations on a multiplatform computing grid.

Authors:  Pekka T Lehtovuori; Tommi H Nyrönen
Journal:  J Chem Inf Model       Date:  2006 Mar-Apr       Impact factor: 4.956

3.  Data management system for distributed virtual screening.

Authors:  Ting Zhou; Amedeo Caflisch
Journal:  J Chem Inf Model       Date:  2009-01       Impact factor: 4.956

4.  A web-based platform for virtual screening.

Authors:  Paul Watson; Marcel Verdonk; Michael J Hartshorn
Journal:  J Mol Graph Model       Date:  2003-09       Impact factor: 2.518

Review 5.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

6.  Project-focused activity and knowledge tracker: a unified data analysis, collaboration, and workflow tool for medicinal chemistry project teams.

Authors:  Marian D Brodney; Arthur D Brosius; Tracy Gregory; Steven D Heck; Jacquelyn L Klug-McLeod; Christopher S Poss
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

7.  A novel strategy for improving ligand selectivity in receptor-based drug design.

Authors:  M Pastor; G Cruciani
Journal:  J Med Chem       Date:  1995-11-10       Impact factor: 7.446

Review 8.  Theory of free energy and entropy in noncovalent binding.

Authors:  Huan-Xiang Zhou; Michael K Gilson
Journal:  Chem Rev       Date:  2009-09       Impact factor: 60.622

9.  DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0.

Authors:  Xiaohui Jiang; Kamal Kumar; Xin Hu; Anders Wallqvist; Jaques Reifman
Journal:  Chem Cent J       Date:  2008-09-08       Impact factor: 4.215

10.  AMMOS: Automated Molecular Mechanics Optimization tool for in silico Screening.

Authors:  Tania Pencheva; David Lagorce; Ilza Pajeva; Bruno O Villoutreix; Maria A Miteva
Journal:  BMC Bioinformatics       Date:  2008-10-16       Impact factor: 3.169

View more
  8 in total

1.  A reverse combination of structure-based and ligand-based strategies for virtual screening.

Authors:  Alvaro Cortés-Cabrera; Federico Gago; Antonio Morreale
Journal:  J Comput Aided Mol Des       Date:  2012-03-07       Impact factor: 3.686

2.  Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.

Authors:  Alvaro Cortés-Cabrera; Garrett M Morris; Paul W Finn; Antonio Morreale; Federico Gago
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  A novel p38 MAPK docking-groove-targeted compound is a potent inhibitor of inflammatory hyperalgesia.

Authors:  Hanneke L D M Willemen; Pedro M Campos; Elisa Lucas; Antonio Morreale; Rubén Gil-Redondo; Juan Agut; Florenci V González; Paula Ramos; Cobi Heijnen; Federico Mayor; Annemieke Kavelaars; Cristina Murga
Journal:  Biochem J       Date:  2014-05-01       Impact factor: 3.857

4.  Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.

Authors:  Jie Xia; Terry-Elinor Reid; Song Wu; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2018-05-08       Impact factor: 4.956

5.  IVSPlat 1.0: an integrated virtual screening platform with a molecular graphical interface.

Authors:  Yin Xue Sun; Yan Xin Huang; Feng Li Li; Hong Yan Wang; Cong Fan; Yong Li Bao; Lu Guo Sun; Zhi Qiang Ma; Jun Kong; Yu Xin Li
Journal:  Chem Cent J       Date:  2012-01-05       Impact factor: 4.215

6.  Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field.

Authors:  Maciej Wójcikowski; Piotr Zielenkiewicz; Pawel Siedlecki
Journal:  J Cheminform       Date:  2015-06-22       Impact factor: 5.514

7.  Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression.

Authors:  Olaia Martinez-Iglesias; Alba Casas-Pais; Raquel Castosa; Andrea Díaz-Díaz; Daniel Roca-Lema; Ángel Concha; Álvaro Cortés; Federico Gago; Angélica Figueroa
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

8.  Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis.

Authors:  Haider S Manzer; Ricardo I Villarreal; Kelly S Doran
Journal:  PLoS Pathog       Date:  2022-03-22       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.